(Q41481102)

1 October 2017

1 reference

title

Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy (English)

1 reference

1 October 2017

0 references

Roth DB

1

1 reference

1 October 2017

Flynn HW Jr

series ordinal

2

1 reference

1 October 2017

publication date

1 March 1997

1 reference

1 October 2017

published in

Survey of Ophthalmology

1 reference

1 October 2017

volume

41

1 reference

1 October 2017

issue

5

1 reference

1 October 2017

page(s)

395-401

1 reference

Intraocular ceftazidime as an alternative to the aminoglycosides in the treatment of endophthalmitis

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Toxicity of intravitreous ceftazidime in primate retina

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Comparative intravitreal antibiotic therapy for experimental Enterococcus faecalis endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Macular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Ceftazidime or amikacin: choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Empiric treatment of endophthalmitis. Are aminoglycosides necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Antibiotic combinations: should they be tested?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Aerobic bacteriology of chronic suppurative otitis media without cholesteatoma in children

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Endophthalmitis therapy: changing antibiotic sensitivity patterns and current therapeutic recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Effect of non-beta-lactam antibiotics on penicillin-binding protein synthesis of Enterococcus hirae ATCC 9790.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Endophthalmitis caused by gram-negative organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Resistance to antimicrobial drugs--a worldwide calamity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Late onset endophthalmitis associated with filtering blebs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Endophthalmitis caused by streptococcal species

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Can antibiotic resistance be controlled?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Results in the treatment of postoperative endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Infectious endophthalmitis. Review of 36 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Endophthalmitis: current approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Resistant gram-positive organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

The effect of combinations of cefotiam and other antibiotics on methicillin-resistant Staphylococcus aureus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

In vitro activity of ceftazidime in combination with other antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Immunoregulatory mechanisms of the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Enterococcal infections: an increasing problem in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

Mode of action and in-vitro activity of vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2897%2900005-2

7 January 2021

10.1016/S0039-6257(97)00005-2

Identifiers

DOI

1 reference

release_kzjk3jfivnfxfjsm4tukpgl2de

1 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kzjk3jfivnfxfjsm4tukpgl2de

24 November 2022

mapped directly with Wikidata item

1 reference